AstraZeneca, Bristol-Myers Oppose "Do Over"
AstraZeneca LP and Bristol-Myers Squibb Co. have asked a judge to reject plaintiffs' request that the court award them an additional year's worth of damages, pointing out that the group's earlier...To view the full article, register now.
Already a subscriber? Click here to view full article